efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell...

1
C ORRESPONDENCE Efficacy of Unilateral Versus Bilateral Temporal Artery Biopsies for the Diagnosis of Giant Cell Arteritis EDITOR: BOYEV AND ASSOCIATES (AM J OPHTHALMOLOGY 128:211– 215, August 1999) have provided further evidence that unilateral temporal arteritis can occur. 1 As suggested by Klein and associates, however, it is possible that in patients with differing diagnoses on each side, a normal biopsy was obtained from an abnormal artery having failed to include the skip lesions. 2 It would therefore be of interest to know the length of the biopsy specimens taken from the patients with different diagnoses on each side. The authors merely described the samples as “adequate.” We disagree with the authors’ conclusion that bilat- eral temporal artery biopsy should be performed in all patients in whom giant cell arteritis is suspected when the first biopsy is negative on frozen section. Their results are in fact consistent with Hayreh’s proposal that a temporal artery biopsy of the contralateral side should be performed if the first biopsy is negative and if the patient has signs and symptoms of giant cell arteritis or arteritic anterior ischemic optic neuropathy or both. 2 In the authors’ study, patients with a final clinical diagno- sis of giant cell arteritis had characteristic symptoms of giant cell arteritis. The “false-positive” patient with an ultimate diagnosis of prostatic carcinoma presented with a fever of unknown origin and a raised erythrocyte sedimentation rate. Therefore, with Hayreh’s criteria he would not have required a second biopsy but referral to an internist for a thorough systemic evaluation. We suggest that patients suspected of having giant cell arteritis undergo a unilateral biopsy with samples examined under frozen section. However, if the first biopsy is negative the surgeon may then proceed to perform a biopsy on the contralateral side if the patient has signs and symptoms of giant cell arteritis or arteritic anterior ischemic optic neuropathy or both. JAMES BALL, MB BCHIR RAMAN MALHOTRA, FRCOPHTH Reading, United Kingdom REFERENCES 1. Klein RG, Cambell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clinic Proc 1976;51:504 –510. 2. Hayreh SS, Podhasky PA, Reman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285–296. AUTHOR REPLY THE LENGTHS OF THE TEMPORAL ARTERY BIOPSY SPECI- mens performed on our six patients with differing diag- noses on each side ranged from 8 to 30 mm, with a mean length of 16.7 mm. As noted in our paper, all specimens were cut such that cross-sections were obtained at 0.5 mm intervals. Most skip areas in temporal arteritis are only a few millimeters long. 1–4 Indeed, Chambers and Bernardi- no 4 concluded that there was a 99% probability of finding such an area when a biopsy of at least 4 mm was obtained and serially sectioned. Because the smallest of our biopsy specimens was 8 mm in length, it is possible but extremely unlikely that any of the “negative” results were the result of only biopsying a skip area. Drs Ball and Malhotra state that they disagree with our recommendation to perform a contralateral temporal ar- tery biopsy in patients with “suspected” giant cell arteritis when the first biopsy is negative on frozen section. They recommend contralateral biopsy only in patients with “signs and symptoms of giant cell arteritis or arteritic anterior ischemic optic neuropathy or both.” We believe that their apparent disagreement with our recommenda- tions is really a question of semantics. When we state that someone has “suspected” giant cell arteritis, we mean that he or she has signs or symptoms consistent with giant cell arteritis, including ocular manifestations such as anterior or retrobulbar ischemic optic neuropathy and double vision. Thus, we all agree that if one believes that giant cell arteritis is a likely diagnosis, one should consider a contralateral biopsy. One can adjust one’s degree of suspi- cion according to how comfortable one would feel if he or she missed the diagnosis! LINNEA R. BOYEV, MD, PHD NEIL R. MILLER, MD WILLIAM RICHARD GREEN, MD Baltimore, Maryland © 2000 BY ELSEVIER SCIENCE INC.ALL RIGHTS RESERVED. 0002-9394/00/$20.00 559

Upload: james-ball

Post on 31-Oct-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

CORRESPONDENCE

Efficacy of Unilateral Versus BilateralTemporal Artery Biopsies for theDiagnosis of Giant Cell Arteritis

EDITOR:

BOYEV AND ASSOCIATES (AM J OPHTHALMOLOGY 128:211–

215, August 1999) have provided further evidence thatunilateral temporal arteritis can occur.1 As suggested byKlein and associates, however, it is possible that inpatients with differing diagnoses on each side, a normalbiopsy was obtained from an abnormal artery havingfailed to include the skip lesions.2 It would therefore beof interest to know the length of the biopsy specimenstaken from the patients with different diagnoses on eachside. The authors merely described the samples as“adequate.”

We disagree with the authors’ conclusion that bilat-eral temporal artery biopsy should be performed in allpatients in whom giant cell arteritis is suspected whenthe first biopsy is negative on frozen section. Theirresults are in fact consistent with Hayreh’s proposal thata temporal artery biopsy of the contralateral side shouldbe performed if the first biopsy is negative and if thepatient has signs and symptoms of giant cell arteritis orarteritic anterior ischemic optic neuropathy or both.2 Inthe authors’ study, patients with a final clinical diagno-sis of giant cell arteritis had characteristic symptoms ofgiant cell arteritis. The “false-positive” patient with anultimate diagnosis of prostatic carcinoma presented witha fever of unknown origin and a raised erythrocytesedimentation rate. Therefore, with Hayreh’s criteria hewould not have required a second biopsy but referral toan internist for a thorough systemic evaluation.

We suggest that patients suspected of having giantcell arteritis undergo a unilateral biopsy with samplesexamined under frozen section. However, if the firstbiopsy is negative the surgeon may then proceed toperform a biopsy on the contralateral side if the patienthas signs and symptoms of giant cell arteritis or arteriticanterior ischemic optic neuropathy or both.

JAMES BALL, MB BCHIR

RAMAN MALHOTRA, FRCOPHTH

Reading, United Kingdom

REFERENCES

1. Klein RG, Cambell RJ, Hunder GG, Carney JA. Skip lesionsin temporal arteritis. Mayo Clinic Proc 1976;51:504–510.

2. Hayreh SS, Podhasky PA, Reman R, Zimmerman B. Giantcell arteritis: validity and reliability of various diagnosticcriteria. Am J Ophthalmol 1997;123:285–296.

AUTHOR REPLY

THE LENGTHS OF THE TEMPORAL ARTERY BIOPSY SPECI-

mens performed on our six patients with differing diag-noses on each side ranged from 8 to 30 mm, with a meanlength of 16.7 mm. As noted in our paper, all specimenswere cut such that cross-sections were obtained at 0.5 mmintervals. Most skip areas in temporal arteritis are only afew millimeters long.1–4 Indeed, Chambers and Bernardi-no4 concluded that there was a 99% probability of findingsuch an area when a biopsy of at least 4 mm was obtainedand serially sectioned. Because the smallest of our biopsyspecimens was 8 mm in length, it is possible but extremelyunlikely that any of the “negative” results were the resultof only biopsying a skip area.

Drs Ball and Malhotra state that they disagree with ourrecommendation to perform a contralateral temporal ar-tery biopsy in patients with “suspected” giant cell arteritiswhen the first biopsy is negative on frozen section. Theyrecommend contralateral biopsy only in patients with“signs and symptoms of giant cell arteritis or arteriticanterior ischemic optic neuropathy or both.” We believethat their apparent disagreement with our recommenda-tions is really a question of semantics. When we state thatsomeone has “suspected” giant cell arteritis, we mean thathe or she has signs or symptoms consistent with giant cellarteritis, including ocular manifestations such as anterioror retrobulbar ischemic optic neuropathy and doublevision. Thus, we all agree that if one believes that giantcell arteritis is a likely diagnosis, one should consider acontralateral biopsy. One can adjust one’s degree of suspi-cion according to how comfortable one would feel if he orshe missed the diagnosis!

LINNEA R. BOYEV, MD, PHD

NEIL R. MILLER, MD

WILLIAM RICHARD GREEN, MD

Baltimore, Maryland

© 2000 BY ELSEVIER SCIENCE INC. ALL RIGHTS RESERVED.0002-9394/00/$20.00 559